BRPI0907203A2 - Forma galênica para a administração de triptanos via transmucosa oral - Google Patents

Forma galênica para a administração de triptanos via transmucosa oral

Info

Publication number
BRPI0907203A2
BRPI0907203A2 BRPI0907203-9A BRPI0907203A BRPI0907203A2 BR PI0907203 A2 BRPI0907203 A2 BR PI0907203A2 BR PI0907203 A BRPI0907203 A BR PI0907203A BR PI0907203 A2 BRPI0907203 A2 BR PI0907203A2
Authority
BR
Brazil
Prior art keywords
active ingredient
triptans
dosage form
transmucosal administration
oral transmucosal
Prior art date
Application number
BRPI0907203-9A
Other languages
English (en)
Inventor
Philippe Perovitch
Marc Maury
Original Assignee
Philippe Perovitch
Marc Maury
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philippe Perovitch, Marc Maury filed Critical Philippe Perovitch
Publication of BRPI0907203A2 publication Critical patent/BRPI0907203A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0907203-9A 2008-01-30 2009-01-29 Forma galênica para a administração de triptanos via transmucosa oral BRPI0907203A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0850571A FR2926721B1 (fr) 2008-01-30 2008-01-30 Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
PCT/FR2009/050134 WO2009095621A1 (fr) 2008-01-30 2009-01-29 Forme galenique pour l'administration de triptans par voie trans-muqueuse buccale

Publications (1)

Publication Number Publication Date
BRPI0907203A2 true BRPI0907203A2 (pt) 2015-07-14

Family

ID=39766922

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907203-9A BRPI0907203A2 (pt) 2008-01-30 2009-01-29 Forma galênica para a administração de triptanos via transmucosa oral

Country Status (15)

Country Link
US (1) US9801815B2 (pt)
EP (1) EP2252263B1 (pt)
JP (1) JP5435659B2 (pt)
CN (1) CN101983052B (pt)
AT (1) ATE516015T1 (pt)
BR (1) BRPI0907203A2 (pt)
CA (1) CA2713163C (pt)
DK (1) DK2252263T3 (pt)
ES (1) ES2369747T3 (pt)
FR (1) FR2926721B1 (pt)
MX (1) MX2010008285A (pt)
PL (1) PL2252263T3 (pt)
PT (1) PT2252263E (pt)
RU (1) RU2492852C2 (pt)
WO (1) WO2009095621A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3031668A1 (fr) 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
NZ501419A (en) * 1997-07-03 2000-09-29 Pfizer Pharmaceutical compositions containing eletriptan hemisulphate and caffeine for treating migraines, depression and eating disorders
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Also Published As

Publication number Publication date
RU2010136277A (ru) 2012-03-10
US9801815B2 (en) 2017-10-31
CA2713163C (fr) 2016-11-08
ATE516015T1 (de) 2011-07-15
RU2492852C2 (ru) 2013-09-20
CN101983052A (zh) 2011-03-02
FR2926721A1 (fr) 2009-07-31
EP2252263A1 (fr) 2010-11-24
WO2009095621A1 (fr) 2009-08-06
PT2252263E (pt) 2011-10-19
CA2713163A1 (fr) 2009-08-06
FR2926721B1 (fr) 2011-07-22
JP5435659B2 (ja) 2014-03-05
US20100298401A1 (en) 2010-11-25
MX2010008285A (es) 2010-10-04
PL2252263T3 (pl) 2011-12-30
ES2369747T3 (es) 2011-12-05
DK2252263T3 (da) 2011-10-31
EP2252263B1 (fr) 2011-07-13
JP2011510962A (ja) 2011-04-07
CN101983052B (zh) 2013-03-20

Similar Documents

Publication Publication Date Title
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
ATE486593T1 (de) Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
CL2011000642A1 (es) Unidad de dosificacion que comprende 25 a 400 mg del acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico; kit farmaceutico que comprende la unidad de dosificacion; y su uso para el tratamiento de fibrosis quistica.
AR078417A1 (es) Composiciones de pelicula sublingual y bucal
DK2120878T3 (da) Doseringsform indeholdende to aktive farmaceutiske ingredienser i forskellige fysiske former
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
ECSP10010514A (es) Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente
ECSP10010588A (es) Formulacion de medicamento solida con liberacion retardada
EA201390394A1 (ru) Никотинсодержащий состав
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
TR201001417A1 (tr) Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu
BRPI0907203A2 (pt) Forma galênica para a administração de triptanos via transmucosa oral
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
ECSP11010998A (es) Formulación galénica que comprende alisquireno y proceso para su preparación mediante granulación de extrusión fundida
MX2015006011A (es) Pastilla medicinal a base de ibuprofeno sodico dihidratado.
WO2011126327A3 (en) Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
CO6331424A2 (es) Formulacion farmaceutica de eprosartan
EA201170950A1 (ru) Новая комбинация активных ингредиентов, содержащая нестероидное противовоспалительное лекарственное средство и производное колхикозида
CL2008003584A1 (es) Uso de la 10-[(3r)-1-azabiciclo]oct-3-ilmetil]-10-h-fenotiazina, o una de sus sales farmaceuticamente aceptables para la preparación de un medicamento util para prevenir o tratar la bronconeumopatia obstructiva.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL